Inmune Bio, Inc.
INMBNasdaqCIK 1711754HealthcareFiscal year ends Dec 31
Reports and events: 345 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2109:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-111207 |
| 2026-09-1416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-099700 |
| 2026-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-086135 |
| 2026-07-3116:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-083961 |
| 2026-07-0107:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-073983 |
| 2026-06-2316:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-071082 |
| 2026-06-1716:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-069611 |
| 2026-06-0216:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-064144 |
| 2026-05-1416:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-056599 |
| 2026-05-0716:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-053338 |
| 2026-05-0516:30 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-052231 |
| 2026-04-2316:06 ET | DEF 14A | Proxy statementPeriod 2026-06-16 | 0001213900-26-047080 |
| 2026-03-3017:29 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-036370 |
| 2026-02-2709:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-021120 |
| 2026-02-2316:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019321 |
| 2026-02-1916:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-018396 |
| 2026-02-1316:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-016385 |
| 2026-01-2716:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-008204 |
| 2025-12-2316:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-125282 |
| 2025-12-1916:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-123880 |
| 2025-12-1016:00 ET | 8-K | 1.02 Termination of a material agreement | 0001213900-25-120067 |
| 2025-12-0816:00 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001213900-25-119217 |
| 2025-12-0516:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-118699 |
| 2025-12-0316:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-117828 |
| 2025-11-2813:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-115921 |
| 2025-11-1816:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112136 |
| 2025-11-1017:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-108315 |
| 2025-10-3016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-104154 |
| 2025-10-3016:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-104141 |
| 2025-10-2816:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-103068 |
| 2025-10-1416:03 ET | DEF 14A | Proxy statementPeriod 2025-11-18 | 0001213900-25-098715 |
| 2025-10-1416:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-098702 |
| 2025-09-3016:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-093930 |
| 2025-08-0716:17 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-073089 |
| 2025-08-0716:08 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-073077 |
| 2025-07-2916:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-068745 |
| 2025-07-2516:47 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-067791 |
| 2025-06-3016:31 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059690 |
| 2025-06-3008:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059252 |
| 2025-06-2616:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-058380 |
| 2025-06-1016:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-053051 |
| 2025-05-1416:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-043270 |
| 2025-05-0816:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-041082 |
| 2025-05-0816:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-041072 |
| 2025-05-0717:20 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-040727 |
| 2025-05-0516:46 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-039733 |
| 2025-04-2116:06 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001213900-25-033742 |
| 2025-04-1616:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-032565 |
| 2025-04-1416:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-031590 |
| 2025-04-0910:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-030129 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:41 ET. Listed shows no prices and gives no investment advice.